Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
4.95 USD -2.56% Intraday chart for Moleculin Biotech, Inc. +6.00% -61.56%
May. 15 Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (Nu 21C06) CI
May. 13 Transcript : Moleculin Biotech, Inc., Q1 2024 Earnings Call, May 13, 2024
ad337822.B4j_77bqpZVFU2EpBEMwWfHzjxX1e60EBlwGeMqEnmY.MP6PgMKO8dI1GStPQnBKCsLC9XejLpRebjhzIY7T1TdGvtLXgY_O9iNjLA~94982c6e3d07ce2a3448e1b6cab23d73
  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. News Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW